NovoCure Ltd. (NVCR)
13.04
-1.19
(-8.36%)
USD |
NASDAQ |
Mar 06, 16:00
13.04
0.00 (0.00%)
After-Hours: 20:00
NovoCure SG&A Expense (TTM) : 417.73M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| LivaNova Plc | 553.37M |
| AtriCure, Inc. | 311.02M |
| Abbott Laboratories | 12.33B |
| Accuray, Inc. | 88.55M |
| Plus Therapeutics, Inc. | 11.09M |